Pravachol News
Bristol-Myers 1Q Profit Falls - Forbes
Sales of the blood-thinner Plavix fell 5 percent to $938 million from $986 million, while sales of cholesterol-lowering drug Pravachol plummeted 75 percent ...
Profits drop at drug maker - Worcester Telegram
Sales of the blood-thinner Plavix fell 5 percent to $938 million, while sales of cholesterol-lowering drug Pravachol plummeted 75 percent to $135 million. ...
FDA OKs two Ranbaxy generics - Phoenix Business Journal
Ranbaxy will also begin making Pravastatin sodium tablets, the generic equivalent to Bristol Myers Squibb's Pravachol, for treatment during cardiovascular ...
Pravastatin nod partially clears NJ cloud over Ranbaxy - Daily News & Analysis
India’s largest drugmaker already has approvals to sell pravastatin (the drug that’s branded as Pravachol) in the 10mg, 20 mg and 40 mg dosage forms. ...
Generics cited as Bristol-Myers' net slips - MarketWatch
Generic competition was the primary drag on Bristol-Myers' top line in the first quarter, with the patent on blockbuster cholesterol drug Pravachol having ...
Ranbaxy: FDA OKs generic Pravachol - BusinessWeek
s cholesterol-lowering drug Pravachol. Pravachol lost patent protection a year ago. Total annual market sales for all strengths were $1.19 billion. ...
Pravachol RSS Feed